Back to Search
JENNIFER TARTAGLIA, M.D.
M.D.
Otolaryngology Physician
NPI: 1891014726IndividualAccepts Medicare
Specialties, Licenses & Credentials
Otolaryngology PhysicianPrimary
Otolaryngology
Code: 207Y00000X
48241(AZ)
CMS Specialties
PrimaryOTOLARYNGOLOGY
Education
UNIVERSITY OF SOUTHERN CALIFORNIA KECK SCHOOL OF MEDICINE
Class of 2008
Research & Publications (20)
Use of predictive markers of HIV disease progression in vaccine trials.
PMID 19200450·Vaccine·2009
6-review
An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses.
PMID 18195071·J Exp Med·2008
2-rct
EV02: a Phase I trial to compare the safety and immunogenicity of HIV DNA-C prime-NYVAC-C boost to NYVAC-C alone.
PMID 18502003·Vaccine·2008
3-trial
Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses.
PMID 19047440·J Exp Med·2008
8-other
Second free tissue transfers in head and neck reconstruction.
PMID 18922338·Otolaryngol Head Neck Surg·2008
8-other
Direct comparison of antigen production and induction of apoptosis by canarypox virus- and modified vaccinia virus ankara-human immunodeficiency virus vaccine vectors.
PMID 17409140·J Virol·2007
4-observational
Improved vaccine protection from simian AIDS by the addition of nonstructural simian immunodeficiency virus genes.
PMID 16365399·J Immunol·2006
4-observational
Systemic immunization with an ALVAC-HIV-1/protein boost vaccine strategy protects rhesus macaques from CD4+ T-cell loss and reduces both systemic and mucosal simian-human immunodeficiency virus SHIVKU2 RNA levels.
PMID 16571790·J Virol·2006
7-preclinical
Characterization of functional and phenotypic changes in anti-Gag vaccine-induced T cell responses and their role in protection after HIV-1 infection.
PMID 15753288·Proc Natl Acad Sci U S A·2005
5-case
Pseudovirion particle production by live poxvirus human immunodeficiency virus vaccine vector enhances humoral and cellular immune responses.
PMID 15827168·J Virol·2005
4-observational
The gene associated with trichorhinophalangeal syndrome in humans is overexpressed in breast cancer.
PMID 16043716·Proc Natl Acad Sci U S A·2005
7-preclinical
Tumoral and immunologic response after vaccination of melanoma patients with an ALVAC virus encoding MAGE antigens recognized by T cells.
PMID 16061912·J Clin Oncol·2005
3-trial
Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I/II ALVAC-HIV/AIDSVAX B/E prime-boost HIV-1 vaccine trial in Thailand.
PMID 15752839·Vaccine·2005
3-trial
Enhanced multiepitope-based vaccines elicit CD8+ cytotoxic T cells against both immunodominant and cryptic epitopes.
PMID 15620483·Vaccine·2005
7-preclinical
European Union and EDCTP strategy in the global context: recommendations for preventive HIV/AIDS vaccines research.
PMID 16153752·Vaccine·2005
8-other
Attenuated poxvirus-based simian immunodeficiency virus (SIV) vaccines given in infancy partially protect infant and juvenile macaques against repeated oral challenge with virulent SIV.
PMID 15671796·J Acquir Immune Defic Syndr·2005
7-preclinical
Absence of immunodominant anti-Gag p17 (SL9) responses among Gag CTL-positive, HIV-uninfected vaccine recipients expressing the HLA-A*0201 allele.
PMID 15265949·J Immunol·2004
8-other
Poxvirus-based vaccine candidates for HIV: two decades of experience with special emphasis on canarypox vectors.
PMID 15285707·Expert Rev Vaccines·2004
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1521 E TANGERINE RD, SUITE 331
ORO VALLEY, AZ 85755 - Phone
- (520) 901-6355
Quick Facts
- NPI
- 1891014726
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 18
- Publications
- 20
Are you this provider?
Claim Your Profile